Larvol Delta - LBA0209âEMBARK-A-Phase-3-Randomized-Study-of-Enzalutamide-or-Placebo-Plus-Leuprolide-Acetate-and-Enzalutamide-Monotherapy-in-Highrisk-Biochemically-Recurrent-Prostate-Cancer

apatorsen (OGX-427) - Achieve Life Sciences

enzalutamide capsule - Generic mfg.

custirsen (OGX-011) - Achieve Life Sciences

http://www.ncbi.nlm.nih.gov/pubmed/37119051

Apr 29, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next